Your Followed Topics

Top 3 joe rogan News Today

#1
Joe Rogan podcast appearance tied to rise in demand for alternative cancer treatment
#1 out of 30.00%

Joe Rogan podcast appearance tied to rise in demand for alternative cancer treatment

  • After Mel Gibson's appearance on Joe Rogan, prescribing of ivermectin–benzimidazole nearly doubled nationwide.
  • The study found larger prescription increases among men, White patients, ages 18–64, and southern residents.
  • Researchers noted the study was observational and could not prove Gibson's appearance caused the spike.
  • No clinical trials currently support the safety or effectiveness of ivermectin–benzimidazole for cancer.
  • Experts say patients should consult qualified healthcare professionals before pursuing such treatments.
  • The research analyzed real-world prescribing data and is limited to observational findings.
  • The episode reportedly drew 60 million views in the month after airing, amplifying its potential impact.
  • Researchers cited possible non-prescription purchases as a factor in the prescription spike.
  • The study did not assess whether patients used ivermectin with standard cancer therapies.
  • Clinicians emphasized seeking professional medical guidance amid speculative off-label use.
Vote 0
0
#2
Joe Rogan Is Getting Roasted for His ‘Severance’ Praise
#2 out of 315.2K est. views

Joe Rogan Is Getting Roasted for His ‘Severance’ Praise

  • Rogan faced sharp online backlash after praising Severance on social media.
  • Cracked notes Rogan’s endorsement contrasts with his usual stance on tech elites.
  • The discussion links Severance to anti-corporate themes despite its Apple production.
  • The article cites Rogan’s past remarks about Amazon amid a tornado incident.
  • Cracked frames Rogan’s Severance take within a broader post-Squid Game media context.
  • The piece notes Apple’s role in Severance and potential hypocrisy.
  • Editorial callouts compare Rogan’s stance with his audience’s expectations.
  • The article situates Rogan’s praise within a broader entertainment-media debate.
  • The piece summarises Rogan’s ongoing influence and the backlash’s scale.
  • The article anchors coverage in a broader media ecosystem around trending topics.
Vote 0
0
#3
Prescriptions for controversial drug shot up 250% for cancer patients after Mel Gibson endorsement
#3 out of 3

Prescriptions for controversial drug shot up 250% for cancer patients after Mel Gibson endorsement

https://nypost.com/2026/05/13/health/controversial-drug-prescriptions-double-after-mel-gibson-remark/https://www.dailymail.com/health/article-15811949/surge-cancer-patients-ivermectin-prescriptions-mel-gibson.html
Nypost.com and 1 more
  • The Daily Mail Online/UK reference confirms a surge in ivermectin prescriptions after Mel Gibson's Joe Rogan podcast, suggesting celebrity influence can rapidly shift patient choices.
  • Researchers note no human clinical trials show ivermectin or fenbendazole are safe or effective for cancer, underscoring that lab/animal data do not translate to proven treatments.
  • The 2025 spike was most pronounced among men, White patients, residents of the US South, and people with cancer, indicating demographic and condition-specific patterns in off-label interest.
  • A UCLA-led study cautions the rise in off-label use may not reflect improved outcomes and calls for caution about substituting proven therapies with unproven ones.
  • Doctors warn that pursuing unproven treatments can delay established, evidence-based cancer therapies and pose real risks to patients.
  • The UCLA study highlights how online influence can affect medical decisions and urges health systems to provide timely, trustworthy information.
  • Gibson's Rogan appearance is linked to increased off-label interest, with the study noting the podcast may have amplified reach for unproven therapies.
  • Ivermectin and fenbendazole are not FDA-approved for cancer treatment, and dosing for animals can be toxic in humans.
  • The Daily Mail piece underscores potential misinformation risks when influential figures advocate unproven cures.
  • The UCLA-led research analyzed data from 67 health care organizations, examining ivermectin prescriptions for adults 18–90 from 2018–2025.
  • The Daily Mail article notes a threefold rise in prescriptions in the US South and a 2.8x rise among men, illustrating pronounced demographic shifts.
  • The reference piece emphasizes that ivermectin's anti-cancer findings are limited to lab and animal studies and not proven in humans.
Vote 1
0

Explore Your Interests

Unlimited Access
Personalized Feed
Full Experience
or
By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Explore Your Interests

Create an account and enjoy content that interests you with your personalized feed

Unlimited Access
Personalized Feed
Full Experience
or
By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Advertisement

Advertisement